These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

100 related items for PubMed ID: 11575182

  • 21. Activity of quinolones against gram-positive cocci: mechanisms of drug action and bacterial resistance.
    Schmitz FJ, Higgins PG, Mayer S, Fluit AC, Dalhoff A.
    Eur J Clin Microbiol Infect Dis; 2002 Sep; 21(9):647-59. PubMed ID: 12373497
    [Abstract] [Full Text] [Related]

  • 22. The in vitro activity of a new fluoroquinolone, ABT-492, against recent clinical isolates of Chlamydia pneumoniae.
    Hammerschlag MR, Roblin PM.
    J Antimicrob Chemother; 2004 Jul; 54(1):281-2. PubMed ID: 15190026
    [No Abstract] [Full Text] [Related]

  • 23. [Quinolone resistance remains low. Doctor H. Grimm, Weingarten, interprets his long years of research. Interview by T.U. Keil].
    Grimm H.
    Fortschr Med; 1988 Oct 30; 106(31):74. PubMed ID: 3181859
    [No Abstract] [Full Text] [Related]

  • 24. Isolation of quinolone-resistant Escherichia coli found in major rivers in Korea.
    Jung D, Lee MY, Kim JM, Lee JC, Cho DT, Lee Y.
    J Microbiol; 2006 Dec 30; 44(6):680-4. PubMed ID: 17205049
    [Abstract] [Full Text] [Related]

  • 25. Quinolones for brucellosis: treating old diseases with new drugs.
    Pappas G, Christou L, Akritidis N, Tsianos EV.
    Clin Microbiol Infect; 2006 Sep 30; 12(9):823-5. PubMed ID: 16882286
    [Abstract] [Full Text] [Related]

  • 26. Antimicrobial activity of a new difluorinated quinolone: lomefloxacin (SC-47111).
    Mattina R, Cocuzza G, Cocuzza CE.
    J Chemother; 1989 Jul 30; 1(4 Suppl):159-61. PubMed ID: 16312351
    [No Abstract] [Full Text] [Related]

  • 27. Vibrio parahaemolyticus chromosomal qnr homologue VPA0095: demonstration by transformation with a mutated gene of its potential to reduce quinolone susceptibility in Escherichia coli.
    Saga T, Kaku M, Onodera Y, Yamachika S, Sato K, Takase H.
    Antimicrob Agents Chemother; 2005 May 30; 49(5):2144-5. PubMed ID: 15855551
    [No Abstract] [Full Text] [Related]

  • 28. From fluoroquinolones to 2-pyridones.
    Hooper DC.
    Lancet; 1995 May 13; 345(8959):1192-3. PubMed ID: 7739303
    [No Abstract] [Full Text] [Related]

  • 29. [Synthesis and antibacterial activity of 5-amino-6, 8-difluoro-1-(5-fluoro-2-pyridyl)-7-(3-methyl-1-piperazinyl)-1, 4-dihydro-4-oxo-3-quinolinecarboxylic acid and its analogues].
    Liu JY, Wei YG, Guo HY.
    Yao Xue Xue Bao; 2001 Jun 13; 36(6):419-22. PubMed ID: 12585124
    [Abstract] [Full Text] [Related]

  • 30. Microbiological studies on lomefloxacin--a new quinolone.
    Newsom SW, Rowland C.
    J Chemother; 1989 Jul 13; 1(4 Suppl):168-9. PubMed ID: 16312354
    [No Abstract] [Full Text] [Related]

  • 31. Effect of the efflux pump inhibitor Phe-Arg-beta-naphthylamide on the MIC values of the quinolones, tetracycline and chloramphenicol, in Escherichia coli isolates of different origin.
    Sáenz Y, Ruiz J, Zarazaga M, Teixidó M, Torres C, Vila J.
    J Antimicrob Chemother; 2004 Mar 13; 53(3):544-5. PubMed ID: 14762057
    [No Abstract] [Full Text] [Related]

  • 32. Mechanisms of quinolone action and microbial response.
    Hawkey PM.
    J Antimicrob Chemother; 2003 May 13; 51 Suppl 1():29-35. PubMed ID: 12702701
    [Abstract] [Full Text] [Related]

  • 33. [Fluoroquinolones and problems of molecular mechanism of their action].
    Egorov AM, Sazykin IuO.
    Antibiot Khimioter; 2000 May 13; 45(8):3-5. PubMed ID: 10989716
    [No Abstract] [Full Text] [Related]

  • 34. Quinolone resistance determinant qnrA3 in clinical isolates of Salmonella in 2000-2005 in Hong Kong.
    Chu YW, Cheung TK, Ng TK, Tsang D, To WK, Kam KM, Lo JY.
    J Antimicrob Chemother; 2006 Oct 13; 58(4):904-5. PubMed ID: 16943211
    [No Abstract] [Full Text] [Related]

  • 35. [Mechanisms of pandrug-resistance of Pseudomonas aeruginosa].
    Shen JL, Zhu DM, Wang MG.
    Zhonghua Yi Xue Za Zhi; 2008 Jul 08; 88(26):1859-62. PubMed ID: 19040025
    [Abstract] [Full Text] [Related]

  • 36. Design, synthesis, and evaluation of psorospermin/quinobenzoxazine hybrids as structurally novel antitumor agents.
    Kim MY, Na Y, Vankayalapati H, Gleason-Guzman M, Hurley LH.
    J Med Chem; 2003 Jul 03; 46(14):2958-72. PubMed ID: 12825936
    [Abstract] [Full Text] [Related]

  • 37. In vitro activity of lomefloxacin, a new difluorinated quinolone, against urinary bacterial isolates: comparison with enoxacin and ofloxacin.
    Azadian BS, Talboys CA, Roberts AP.
    J Chemother; 1989 Jul 03; 1(4 Suppl):176-7. PubMed ID: 16312357
    [No Abstract] [Full Text] [Related]

  • 38. Functionalized N(2-oxyiminoethyl) piperazinyl quinolones as new cytotoxic agents.
    Rajabalian S, Foroumadi A, Shafiee A, Emami S.
    J Pharm Pharm Sci; 2007 Jul 03; 10(2):153-8. PubMed ID: 17706174
    [Abstract] [Full Text] [Related]

  • 39. On the physical interpretation of QSAR models.
    Stanton DT.
    J Chem Inf Comput Sci; 2003 Jul 03; 43(5):1423-33. PubMed ID: 14502475
    [Abstract] [Full Text] [Related]

  • 40. New quinolone resistance phenomenon in Salmonella enterica: nalidixic acid-susceptible isolates with reduced fluoroquinolone susceptibility.
    Hakanen AJ, Lindgren M, Huovinen P, Jalava J, Siitonen A, Kotilainen P.
    J Clin Microbiol; 2005 Nov 03; 43(11):5775-8. PubMed ID: 16272517
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.